GENE ONLINE|News &
Opinion
Blog

Checkpoint Inhibitor
Implantable “Drug Factory” Eradicates Mesothelioma in Mice When Combined with a Checkpoint Inhibitor
2022-09-06
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
Amgen, Kyowa Kirin Renew Long-Standing Partnership to Promote Atopic Dermatitis Therapy
2021-06-02
A Glance at Gene Therapy Advances in Cancer
2021-05-16
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Bristol Myers Squibb to Acquire Forbius for Augmenting TGF-beta Inhibitors
2020-08-25
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
Weekly in Asia(0421-0427 )
2019-04-30
LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top